Tanya Golubchik Selected Research

Tanya Golubchik Research Topics

7	Infections 02/2024 - 04/2017
4	COVID-19 01/2022 - 01/2021
2	Fever (Fevers) 12/2022 - 10/2021
2	Tuberculosis (Tuberculoses) 10/2018 - 01/2011
1	Persistent Infection 02/2024
1	Hepatitis B 10/2023
1	Smallpox (Variola) 01/2023
1	Mpox (monkeypox) 01/2023
1	Respiratory Sounds (Crackle) 12/2022
1	Respiratory Syncytial Virus Infections 12/2022
1	Dyspnea (Shortness of Breath) 10/2021
1	Cough 10/2021
1	Ageusia (Hypogeusia) 10/2021
1	Anosmia 10/2021
1	Abscess 12/2017
1	Cross Infection (Nosocomial Infection) 04/2017
1	Sepsis (Septicemia) 03/2012

3	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 10/2018
3	VaccinesIBA 01/2022 - 10/2021
2	ChAdOx1 nCoV-19IBA 10/2021 - 10/2021
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2011
1	Blood Group Antigens (Blood Groups)IBA 02/2024
1	Anti-Idiotypic AntibodiesIBA 02/2024
1	Viral RNAIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	P-2 (P 2)IBA 10/2021
1	Nucleic AcidsIBA 10/2021
1	MenACWYIBA 10/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Surface Antigens (Surface Antigen)IBA 12/2017
1	Antimicrobial PeptidesIBA 12/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2017
1	FluoroquinolonesIBA 04/2017
1	Methicillin (Metin)FDA Link 03/2012

2	Therapeutics 01/2022 - 01/2022
1	Art Therapy 12/2023
1	Critical Care (Surgical Intensive Care) 12/2022